APOB and type 2 diabetes mellitus: In 2006, we first proposed that high plasma numbers of apoB-lipoproteins (plasma apoB), more than 90% of which are LDL, may be a promotor and not a mere consequence of T2D as it predicted several plasma pro-inflammatory markers including C-reactive protein and IL-61.